SARS-CoV-2 Multiplex IgG+IgA+IgM kit CE-IVD

Anti-SARS-CoV-2 Multiplex serology assay
One of the most sensitive and reliable SARS-CoV-2 assays available in the market.

Flow Cytometry SARS-CoV-2 multiantigen test
Simultaneously target four separate SARS-Cov-2 viral proteins and 3 immunoglobulins.

Multiantigen IgG+IgA+IgM is a multiplex, microsphere-based, highly sensitive and specific assay that measure the presence or absence of antibodies against four different SARS-CoV-2 antigens simultaneously.
- RBD: Detecting SARS-CoV-2 neutralizing antibodies.
- SPIKE: Identifying immune response after vaccination.
- NUCLEOCAPSID: Identifying immune response to natural infection.
- MPRO: Identifying immune response to viral replication.

Three reporter channels simultaneously
- Just one sample
- 4 different proteins
- 3 immunoglobulins

Differentiating immune response by virus and vaccinationThis serological bead-based assay has demonstrated to provide a wider range of information about the immune system response to SARS-CoV-2 than any other assay in the market, and it is performed in just 2 hours.